The European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML). A Prospective, Population-Based European Registry.
Michele Baccarani(University of Bologna), Joerg Hasford(Ludwig-Maximilians-Universität München), Richard E. Clark(The Football Association), Susanne Saußele(University of Mannheim), Francesca Rancati(Novartis (Italy)), Edward Laane(North Estonia Medical Centre), Rüdiger Hehlmann(Heidelberg University), Adriana Coliță(Institutul Clinic Fundeni), Doris Lindörfer(Zimmer Biomet (Germany)), Andrija Bogdanović(University of Belgrade), Panayiotis Panayiotidis(National and Kapodistrian University of Athens), Paul Costeas(Deakin University), Andreas Hochhaus(Jena University Hospital), Irena Preložnik Zupan(Ljubljana University Medical Centre), Juan Luis Steegmann(Hospital Universitario de La Princesa), Kimmo Porkka(Helsinki University Hospital), António Almeida(Hospital da Luz), Jiřı́ Mayer(Masaryk University), Sandra Lejniece(Riga East University Hospital), Andrey Zaritskey, Karel Indrák(Palacký University Olomouc), Laimonas Griškevičius(Vilnius University), Lara Montrucchio(Novartis (Italy)), Tamás Masszi, Josef Thaler(Thrombolysis in Myocardial Infarction Study Group), Gert J. Ossenkoppele(Dutch Cancer Society), Gregor Verhoef(Universitair Ziekenhuis Leuven), Joëlle Guilhot(Inserm), Andrzej Hellmann(Gdańsk Medical University), Boris Labar(Radboud University Nijmegen), Anna Turkina(National Medical Research Center for Hematology), Bengt Simonsson(Uppsala University Hospital), Gianantonio Rosti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 0
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k